Autoimmune Diseases Working Party (ADWP)
Study type:
Study number:
8410-025
Type of Stem Cell Treatment:
Autologous
Diseases:
Short title:
NISSc-2
Primary objective:
To survey different practices of EBMT centres for post-AHSCT management for SSC patients
Key inclusion criteria:
Autologous HSCT
Age above 18 years at time of autologous HSCT.
First AHSCT for a diagnosis of progressive systemic sclerosis according to 2013 EULAR-ACR criteria
Age above 18 years at time of autologous HSCT.
First AHSCT for a diagnosis of progressive systemic sclerosis according to 2013 EULAR-ACR criteria
Country:
Principal investigator:
Pr Dominique Farge
EBMT Study coordinator:
Manuela Badoglio
Study coordinator email:
manuela.badoglio@upmc.fr